By Business/Source
Currency:USD
2026/Q2
Stock NameRevenueRatio
Thrombectomy258.98M66.40%
Embolization and Access131.07M33.60%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States1.09B77.78%
International311.9M22.22%